Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great due diligence here: https://newsytrends.com/2023/09/11/super-fresh-foods-inc-otcmkts-gspt/
$BLIS- News out today. This stock is on the way to a major run. Load and buckle up!
I think we see a nice run if we can break .03 and hold it today or tomorrow. This news may very well be the catalyst it needs.
I think its obvious something is going on here with this nice volume on a down market day. More to come in my opinion. RADAR on for NEWS
$STRH - Just getting started IMO
With this volume you would think there may be some news on the way
AFFU- this partnership with DELL is only going to get bigger. This one should do very well when the DELL shareholders start to see whats happening.
This company is getting ready to come out from under the radar and pop on everyone's watch list. Big news on the horizon IMO.
This company is flying under the radar. If the public got exposure on the details of this company it would take off! Hopefully some good exposure will be forthcoming.
NEWS!!!
Earth Gen Biofuel Inc.’s Subsidiary Expands Manufactured Home Sales Into Nevada and Arizona
Press Release | 08/30/2022
Salem, Oregon, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Earth Gen-Biofuel Inc. (OTC:EGBB) wholly owned manufacturing subsidiary, International Housing Concepts Inc. (“IHC”), starts manufacturing of two large home orders for delivery to the Southwest. First deliveries are scheduled for mid-October. Pending factory certification, these production runs are scheduled to include HUD certified homes for a multi-home residential community in Northern Nevada and Park Model Homes for a project in Arizona.
The Nevada homes are being manufactured as part of a multiphase project that the developer has indicated could include up to 400 homes. The Sparks project is being developed as the Chalets Residential Community and will consist of a single-unit manufactured homes.
Scott DeBo, IHC President stated, “Achieving this first production order for these units is a validation of our plan to support the market trend for developers using larger floor plans in their developments. IHC’s expectation is for current contracts to be a substantial part of 2022 and 2023 sales. Based on forecasted sales these home deliveries have the potential to reach over $12,000,000 over the next three quarters if the delivery and manufacturing schedules are met.”
Mr. DeBo added, “Current production contracts validate the hard work and creativity of our product development team and is a good example of our commitment to working closely with our clients to build the products they envision. IHC is working with other developers to design homes that will meet certain local and national building codes for manufactured housing as well as consumer financing requirements”.
IHC has been delivering our Park Model homes specifically designed for the Southwest over the last five months. These homes represent the expansion of the company’s sales strategy to build an order book that will support the planned expansion into a Phoenix regional production facility. Sales in the region in 2022 have already exceeded $1,100,000. This group of homes is now being produced in the Salem facility. An additional $1,800,000 in homes is expected to be built and delivered to the Southwest by year end if current production levels remain constant.
The company’s goal based on existing relationships in the Pacific Northwest, and now the Southwest is to build order-flow to over 300 homes a year to support IHC’s entry into the Southwest region. The Company expects to move the production of HUD home orders for Nevada and Arizona to the Phoenix facility. The new facility will produce the Company’s successful line of Park model RVs and the larger HUD certified models. The company is still in the process of finalizing negotiations for a new factory location and while success is not guaranteed, we continue to plan for the start of manufacturing late in 2022 or Q-1 2023.
The Phoenix facility is being designed to produce 360 homes a year and will accommodate the construction of homes up to 990 square feet. The new designs introduced in 2022, include larger homes from 425 to 980 square feet, ski chalets, 4 star resort cabins and homes with upgraded designs that recognize local environments.
NEWS OUT-
CB Scientific, Inc. (CBSC) and Shenzhen Pump Medical Co., Ltd. Announce Cooperative Manufacturing Agreement for Chinese Market
Press Release | 08/23/2022
Shenzhen Pump Medical Co. Ltd. to formally become the recognized manufacturer of record for CBSC's myCam device, cloud-based software, and smartphone app in China.
SHENZHEN, CHINA and ESCONDIDO, CA / ACCESSWIRE / August 23, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, is pleased to announce that it has entered into a cooperative manufacturing agreement (CMA) with Shenzhen Pump Medical Co., Ltd. (Shenzhen Pump), a privately held, well-established medical device manufacturer, developer and distributor of cardiovascular medical equipment and devices based in Shenzhen, Nanshan, China.
Under the terms of the CMA, Shenzhen Pump will formally be recognized as the qualified manufacturer of record in China for the Company's innovative myCam cardiac event monitor, interactive cloud-based acquisition software, and the associated We Chat smartphone app. As a certified ISO 13485, and Quality Systems Regulations compliant device manufacturer in that country, Shenzhen Pump fulfills the manufacturing regulatory requirements of the National Medical Products Administration (NMPA - formally China's FDA) medical device regulatory approval process for the Company's myCam device in China.
"I am extremely excited to welcome Shenzhen Pump as our manufacturing partner in China," said Charles Martin, Chief Executive Officer of CB Scientific, Inc. "They have a reputation of manufacturing excellence in that country which we believe will facilitate completion of the final regulatory approval process steps necessary to be awarded a clearance to market from the NMPA for the myCam device in the Chinese market."
While timing of the overall product approval process was temporarily hindered by the COVID-19 pandemic, CBSC was able to continue accruing significant market effectiveness data. Since 2019, the Company's successful onsite field evaluation trial for myCam includes over 2.1 million patient interactions, with a 99+% efficiency performance rating, located at 46 different hospitals in Ningbo, Shenzhen, Dongguan, and Guangzhou, China.
CBSC plans to immediately commence collaboration with Shenzhen Pump to prepare their facility for myCam device manufacturing, deployment of a new Chinese cloud-based software portal for validation, test and support purposes, as well as development of an enhanced WeChat smartphone app to seamlessly function with the newly manufactured devices. Subsequent to a successful NMPA audit confirming Shenzhen Pump meets requisite manufacturing standards, a limited number of pre-production myCam devices will be placed with existing hospital evaluation locations for final validation performance testing.
As additional new developments occur, CB Scientific, Inc. plans to make timely announcements through press releases and regulatory filings to keep its shareholders, industry participants, and the public markets informed.
Great article! I have been following this company for a while now and I'm glad to see filings up to date and some trading ramping up. I think this one will move easily over $1.00 once the public starts getting a look into this huge potential.
Unfortunately this stock doesn't have a few months. A few weeks maybe then its over.
$URYL looking like it may be waking up a bit here at the bottom.
$URYL maybe time for a bounce here.
New to this board and I have a question. Is the flip game the only thing going on with this stock? Are their any actual long term holders here?
$DGDM news today was very nice.
https://finance.yahoo.com/news/dgdm-provides-further-analysis-specific-123000543.html
This looks like the beginning of something really good. These positive results announced today puts the company one step closer to some big revenue in the stream.
Looks like the share price has settled in this .60 - .70 range waiting for next surge upward. I think this will run over $1.00 very soon. Looking for news or update soon.
Whenever we get an update from the company concerning its business I think we see the share price run past .50 pretty easy. If you check otcmarkets.com/orgh you will see that the dtc share count is only 633k shares. Tiny amount!
Moved up in that .30 range today. It seems this is thinning out nicely.
.24 x .2745 is looking nice. This looks extremely thin now. News of sales should get some attention.
Uptrend looking good here. I think we see .50 pretty soon. Very few shares available at this level.
Here is the short report.
Click Here
SHMP news today. Chart looks decent. Time for a run.
NaturalShrimp, Inc. and Natural Aquatic Systems (NAS) Announces Agreement with Hydrenesis, Inc. on New Hydrogas® Technology
Press Release | 08/13/2019
DALLAS, TX, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NaturalShrimp, Inc. (OTCQB: SHMP), the aquaculture company that developed and patented the first commercially-operational RAS for shrimp, and its majority-owned, technology subsidiary, Natural Aquatic Systems, announced today that they have entered into an agreement that will expand their first commercially-viable system for growing aquatic species indoors to include not just shrimp, but all aquatic species, with the integration of Hydrogas®, the patent-pending, anti-oxidant treatment offered by Hydrenesis, Inc.
NaturalShrimp is already in the process of expanding existing operations, and this additional patented-pending technology will allow its subsidiary, Natural Aquatic Systems, to expand its RAS capabilities outside of shrimp to cover all aquatic fresh and saltwater species, significantly expanding the Company’s market reach. NaturalShrimp is also testing the Hydrogas® technology in combination with its own ChlorineGas technology to determine what other efficiencies can be added to its current RAS methodology. NaturalShrimp and F&T Water Solutions, LLC have already received U.S. Patent No. 10,163,199 B2 for the Recirculating Aquaculture System and Treatment Method for Aquatic Species (December 25, 2018) and NaturalShrimp maintains the exclusive worldwide rights for any shrimp species utilizing this patent.
Gerald Easterling, President of NaturalShrimp, commented, “We continue to improve operations on our initial focus of bringing shrimp to market, and with this agreement, we are poised to expand our capabilities to additional species as well. The additional species proposed for further testing are barramundi, salmon, and tilapia.”
Peter Letizia, CEO of F&T Water Solutions, added: “As a technology partner of NaturalShrimp, we never stop looking for new innovations in RAS technology. Partnering with Hydrenesis and employing their Hydrogas® technology, gives us a significantly upgraded anti-oxidation capability as opposed to the standard, floating-bed, bioremediation utilized in most indoor aquaculture facilities.”
David Antelo, CEO of Hydrenesis, said: “We’re happy to provide technology that gives NaturalShrimp control over those oxidation processes that create so much havoc in the tanks. We believe that the key to profitability and success in the aquaculture business moving forward will be in eliminating the devastating effects of oxidation using anti-oxidant (reducing) technologies like ours.”
ABOUT NATURAL SHRIMP: NaturalShrimp, Inc. is a publicly traded aqua-tech Company, headquartered in Dallas, with production facilities located near San Antonio, Texas. The Company has developed the first commercially viable system for growing shrimp in enclosed, salt-water systems, using patented technology to produce fresh, never frozen, naturally grown shrimp, without the use of antibiotics or toxic chemicals. NaturalShrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp.
ABOUT F&T WATER SOLUTIONS, LLC: Specializes in Electrocoagulation and Gas and Plasma Infusion Technologies for Desalination and Solids Waste Management for Aquaculture, Food & Beverage Processing, Hydraulic Fracturing, Produced Oil & Natural Gas Wastewater and Landfill Leachate.
ABOUT HYDRENESIS, INC.: Hydrenesis, Inc. is a commercialization company that partners with IP Holders of disruptive technologies to develop and commercialize new markets strategically, without directly challenging industry incumbents or regulators. The Company’s technologies deliver unique solutions related to water-related oxidation control, chemical reduction, contaminant removal, neutralization of Nitrogen compounds, desalination, and purification
SHMP news today looks promising.
NaturalShrimp, Inc. and Natural Aquatic Systems (NAS) Announces Agreement with Hydrenesis, Inc. on New Hydrogas® Technology
Press Release | 08/13/2019
DALLAS, TX, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NaturalShrimp, Inc. (OTCQB: SHMP), the aquaculture company that developed and patented the first commercially-operational RAS for shrimp, and its majority-owned, technology subsidiary, Natural Aquatic Systems, announced today that they have entered into an agreement that will expand their first commercially-viable system for growing aquatic species indoors to include not just shrimp, but all aquatic species, with the integration of Hydrogas®, the patent-pending, anti-oxidant treatment offered by Hydrenesis, Inc.
NaturalShrimp is already in the process of expanding existing operations, and this additional patented-pending technology will allow its subsidiary, Natural Aquatic Systems, to expand its RAS capabilities outside of shrimp to cover all aquatic fresh and saltwater species, significantly expanding the Company’s market reach. NaturalShrimp is also testing the Hydrogas® technology in combination with its own ChlorineGas technology to determine what other efficiencies can be added to its current RAS methodology. NaturalShrimp and F&T Water Solutions, LLC have already received U.S. Patent No. 10,163,199 B2 for the Recirculating Aquaculture System and Treatment Method for Aquatic Species (December 25, 2018) and NaturalShrimp maintains the exclusive worldwide rights for any shrimp species utilizing this patent.
Gerald Easterling, President of NaturalShrimp, commented, “We continue to improve operations on our initial focus of bringing shrimp to market, and with this agreement, we are poised to expand our capabilities to additional species as well. The additional species proposed for further testing are barramundi, salmon, and tilapia.”
Peter Letizia, CEO of F&T Water Solutions, added: “As a technology partner of NaturalShrimp, we never stop looking for new innovations in RAS technology. Partnering with Hydrenesis and employing their Hydrogas® technology, gives us a significantly upgraded anti-oxidation capability as opposed to the standard, floating-bed, bioremediation utilized in most indoor aquaculture facilities.”
David Antelo, CEO of Hydrenesis, said: “We’re happy to provide technology that gives NaturalShrimp control over those oxidation processes that create so much havoc in the tanks. We believe that the key to profitability and success in the aquaculture business moving forward will be in eliminating the devastating effects of oxidation using anti-oxidant (reducing) technologies like ours.”
ABOUT NATURAL SHRIMP: NaturalShrimp, Inc. is a publicly traded aqua-tech Company, headquartered in Dallas, with production facilities located near San Antonio, Texas. The Company has developed the first commercially viable system for growing shrimp in enclosed, salt-water systems, using patented technology to produce fresh, never frozen, naturally grown shrimp, without the use of antibiotics or toxic chemicals. NaturalShrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp.
ABOUT F&T WATER SOLUTIONS, LLC: Specializes in Electrocoagulation and Gas and Plasma Infusion Technologies for Desalination and Solids Waste Management for Aquaculture, Food & Beverage Processing, Hydraulic Fracturing, Produced Oil & Natural Gas Wastewater and Landfill Leachate.
ABOUT HYDRENESIS, INC.: Hydrenesis, Inc. is a commercialization company that partners with IP Holders of disruptive technologies to develop and commercialize new markets strategically, without directly challenging industry incumbents or regulators. The Company’s technologies deliver unique solutions related to water-related oxidation control, chemical reduction, contaminant removal, neutralization of Nitrogen compounds, desalination, and purification
Bids seem to be building over the past few days. A very good sign.
.08 bid whack..maybe this thing starts trading a little
OSCI ready to move up. This could move fast with the latest news.
$OSCI looks like its ready to move up after their news
Hoping to get some cheap shares down here, but it seems our seller is not going to budget under .16 at the moment.
Hopefully eyes will start to get on this company. Sales are beginning it appears.
If this was a real deal, the stock would not be trading at .19
Talk has been going on for a long time on this one. Its time to produce and stop the $40k per month bleed that is leading us deeper in the hole.
NDYN entering SQUEEZE MODE on news and bitcoin strength
NDYN SQUEEZE in play
NDYN on SQUEEZE ALERT
NDYN low floater>>> squeeze may be in play here
NDYN - Adding here looking for .06+
NDYN Dividend payout announced to begin in September.